KV Pharma seeks Chapter 11 bankruptcy protection - Businessweek
08/06/12
KV Pharma seeks Chapter 11 bankruptcy protection
Businessweek
NEW YORK (AP) — K-V Pharmaceutical Co. has filed filing for Chapter 11 bankruptcy protection as it deals with weak sales, a payment related to its costly preterm birth drug Makena, and sanctions related to past manufacturing problems. The St. Louis ...
KV Pharmaceutical Files for Chapter 11Wall Street Journal
[more]
Businessweek
NEW YORK (AP) — K-V Pharmaceutical Co. has filed filing for Chapter 11 bankruptcy protection as it deals with weak sales, a payment related to its costly preterm birth drug Makena, and sanctions related to past manufacturing problems. The St. Louis ...
KV Pharmaceutical Files for Chapter 11Wall Street Journal
- Feeds Categories:
